当前位置:首页 - 行情中心 - 康拓医疗(688314) - 财务分析 - 现金流量表

康拓医疗

(688314)

  

流通市值:31.16亿  总市值:31.16亿
流通股本:8123.92万   总股本:8123.92万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金187,723,096.3192,033,729.75367,834,458.62273,582,045.96
  收到其他与经营活动有关的现金7,982,279.092,367,824.9119,255,425.5615,381,759.46
  经营活动现金流入小计195,705,375.494,401,554.66387,089,884.18288,963,805.42
  购买商品、接受劳务支付的现金29,868,048.8319,630,189.3245,307,204.2334,755,614.76
  支付给职工以及为职工支付的现金43,375,022.9224,814,828.1777,971,565.858,452,631.1
  支付的各项税费26,320,887.2712,247,603.0153,964,56743,593,739.23
  支付其他与经营活动有关的现金33,951,560.7315,681,528.4269,591,992.2742,507,087.9
  经营活动现金流出小计133,515,519.7572,374,148.92246,835,329.3179,309,072.99
  经营活动产生的现金流量净额62,189,855.6522,027,405.74140,254,554.88109,654,732.43
二、投资活动产生的现金流量:
  取得投资收益收到的现金699,155.63332,721.652,207,588.541,359,111.12
  处置固定资产、无形资产和其他长期资产收回的现金净额2,8001,500661,079.18661,074.98
  收到的其他与投资活动有关的现金468,000,000227,000,000665,000,000345,000,000
  投资活动现金流入小计468,701,955.63227,334,221.65667,868,667.72347,020,186.1
  购建固定资产、无形资产和其他长期资产支付的现金20,578,374.339,596,251.7247,397,964.7335,221,527.01
  投资支付的现金15,000,00015,000,00032,848,39032,819,830
  取得子公司及其他营业单位支付的现金0010,775,066.8710,775,066.87
  支付其他与投资活动有关的现金538,000,000308,000,000668,202,515420,000,000
  投资活动现金流出小计573,578,374.33332,596,251.72759,223,936.6498,816,423.88
  投资活动产生的现金流量净额-104,876,418.7-105,262,030.07-91,355,268.88-151,796,237.78
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金15,548,333.98465,020.7342,695,997.0927,555,897.22
  支付其他与筹资活动有关的现金1,843,369652,270.533,250,214.442,386,755.88
  筹资活动现金流出小计17,391,702.981,117,291.2645,946,211.5329,942,653.1
  筹资活动产生的现金流量净额-17,391,702.98-1,117,291.26-45,946,211.53-29,942,653.1
四、汇率变动对现金及现金等价物的影响156,466.3473,572.93-329,516.43-628,129.17
五、现金及现金等价物净增加额-59,921,799.69-84,278,342.662,623,558.04-72,712,287.62
  加:期初现金及现金等价物余额377,743,344.37377,743,344.37375,119,786.33375,119,786.33
  期末现金及现金等价物余额317,821,544.68293,465,001.71377,743,344.37302,407,498.71
补充资料:
  净利润54,519,423.06-87,635,989.83-
  资产减值准备778,139.74-5,341,474.23-
  固定资产和投资性房地产折旧3,978,815.88-7,417,690.45-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧3,978,815.88-7,417,690.45-
  无形资产摊销2,253,378.88-4,089,956-
  长期待摊费用摊销1,670,705.5-3,429,793.94-
  处置固定资产、无形资产和其他长期资产的损失0--463,920.09-
  固定资产报废损失13,476.46-21,623.82-
  公允价值变动损失857,482.9-0-
  财务费用1,134,572.27-2,174,544.63-
  投资损失6,366,153.01-12,589,836.25-
  递延所得税-410,873.15--1,405,643.35-
  其中:递延所得税资产减少33,722.54--802,493.66-
    递延所得税负债增加-444,595.69--603,149.69-
  存货的减少-935,076.52-6,778,111.77-
  经营性应收项目的减少-4,293,655.23-2,910,474.29-
  经营性应付项目的增加-5,682,062.6-6,469,500.25-
  其他570,085.55-0-
  债务转为资本--0-
  一年内到期的可转换公司债券--0-
  融资租入固定资产--0-
  现金的期末余额317,821,544.68-377,743,344.37-
  减:现金的期初余额377,743,344.37-375,119,786.33-
  加:现金等价物的期末余额--0-
  减:现金等价物的期初余额--0-
  现金及现金等价物的净增加额-59,921,799.69-2,623,558.04-
公告日期2025-08-292025-04-292025-03-282024-10-29
审计意见(境内)标准无保留意见
TOP↑